Aull & Monroe Investment Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,800
Closed -$224K 130
2024
Q3
$224K Hold
2,800
0.1% 123
2024
Q2
$201K Buy
+2,800
New +$206K 0.1% 126
2024
Q1
Sell
-2,800
Closed -$216K 136
2023
Q4
$216K Buy
+2,800
New +$184K 0.11% 122
2023
Q3
Sell
-2,800
Closed -$229K 133
2023
Q2
$229K Hold
2,800
0.12% 122
2023
Q1
$208K Hold
2,800
0.11% 129
2022
Q4
$232K Buy
+2,800
New +$222K 0.12% 117
2022
Q3
Sell
-2,800
Closed -$243K 131
2022
Q2
$243K Hold
2,800
0.12% 119
2022
Q1
$303K Hold
2,800
0.14% 113
2021
Q4
$362K Hold
2,800
0.16% 104
2021
Q3
$339K Hold
2,800
0.17% 104
2021
Q2
$315K Hold
2,800
0.15% 111
2021
Q1
$267K Hold
2,800
0.13% 114
2020
Q4
$222K Buy
+2,800
New +$203K 0.12% 121
2019
Q3
Sell
-4,000
Closed -$209K 133
2019
Q2
$209K Sell
4,000
-2,600
-39% -$131K 0.11% 124
2019
Q1
$328K Hold
6,600
0.18% 100
2018
Q4
$238K Hold
6,600
0.14% 114
2018
Q3
$337K Hold
6,600
0.16% 104
2018
Q2
$245K Hold
6,600
0.13% 116
2018
Q1
$249K Hold
6,600
0.13% 121
2017
Q4
$214K Buy
+6,600
New +$210K 0.11% 128

Other funds holding TECH

Aull & Monroe Investment Management's TECH Position: Q4 2024 in Review

Aull & Monroe Investment Management sold out of Bio-Techne (TECH) in Q4 2024, closing a stake of 2,800 shares — an estimated $224K sold.

Aull & Monroe Investment Management first reported a position in TECH in Q4 2017 and held it in 20 quarters. The position peaked at $362K in Q4 2021. 577 funds tracked by Wall St. Rank hold TECH as of Q4 2024.

  • Aull & Monroe Investment Management reported no remaining Bio-Techne position as of Q4 2024 after selling out during the quarter.
  • Aull & Monroe Investment Management sold 2,800 Bio-Techne shares in Q4 2024, an estimated $224K.
  • Aull & Monroe Investment Management first reported a position in Bio-Techne in Q4 2017 and held it in 20 quarters.
  • Aull & Monroe Investment Management's Bio-Techne position peaked at $362K in Q4 2021.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2024.

Based on Aull & Monroe Investment Management's 13F filing for Q4 2024, filed 7 Feb 2025.